Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Eli Lilly And Co issues FY 2014 guidance; net income guidance above analysts' estimate


Tuesday, 7 Jan 2014 07:00am EST 

Eli Lilly And Co:Sees FY 2014 revenue to be between $19.2 billion and $19.8 billion.Sees FY 2014 Earnings per share to be in the range of $2.77 - $2.85, reflecting the impact of patent expirations.Sees 2014 net income of $3.0 billion.Says it reaffirms commitment to maintain dividend at least at current level.Revenues of $19.5 billion, net income of $2.95 billion and EPS of $2.78 for fiscal 2014 - Thomson Reuters I/B/E/S Estimates. 

Company Quote

54.062
0.5 +0.93%
8:44am EST